Last week, the eyes of all the key stakeholders in the Antibody Drug Conjugates (ADCs) space were on the developments happening in San Diego, California, at the 6th World ADC Awards.  The awards were meant to recognize the companies that are driving innovation in the field of ADCs Therapeutics. With six approved and marketed drugs,